General MedicationsORALGeneric

PROMETHAZINE VC PLAIN

PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE

Standard Dose

5MG/5ML;6.25MG/5ML

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview PROMETHAZINE VC PLAIN is listed in Drugs@FDA under application 088897 (ANDA).

Marketing status: Discontinued Active ingredient PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE Form and strength SYRUP;ORAL - 5MG/5ML;6.25MG/5ML Sponsor XTTRIUM LABS INC Submission history Latest submission status date: 1990-04-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROMETHAZINE VC PLAIN is listed in Drugs@FDA under application 088897 (ANDA). Marketing status: Discontinued Active ingredient PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE Form and strength SYRUP;ORAL - 5MG/5ML;6.25MG/5ML Sponsor XTTRIUM LABS INC Submission history Latest submission status date: 1990-04-04 00:00:00. Submission type: SUPPL.

Monitoring

• Review priority: STANDARD
• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.